Thank you for supporting ACA’s No Match for Mom! Campaign. With your help we reached our $30,000 goal. The money raised will provide essential services for low income families caring for their loved one at home. https://alzca.org/mom/
Join ACA’s Jr. Board at the Taco Mama in Homewood, Monday, May 16, 5 pm -9 pm, for a % of sales event to benefit the Lindy Harrell Pre-Doctoral Scholars Program in Alzheimer’s disease research at UAB. Dine in or take out. Flyer attached.
M4A webinar, May 17, 10 11 CT: Grief Share: The Journey from Mourning to Joy-Webinar — Human Resource Options
In-person and zoom Support Groups:
- ACA’s group with Miller & Vance, Tuesday, May 17, 11 – noon CT. Call (205) 871-7970 or email@example.com. Join us on zoom: https://us02web.zoom.us/j/86450491838
- Pell City group, first Thursdays of the month at 6:30; and the third Tuesdays of the month at 6:30. Contact Bit Thomaston, firstname.lastname@example.org
- CJFS CARES, Mondays at 3 pm, contact Pam Leonard, email@example.com.
- Founders Place at St. Luke’s Episcopal Church, Tuesday’s at 10 am, contact Susan Logan, firstname.lastname@example.org
- West Alabama Area Agency on Aging, Caregiver Support Group, Tuesdays, contact Nikki Poe, email@example.com.
- The Oaks on Parkwood, 4th Tuesday’s, 10:00 am, Contact: Karen Glover, firstname.lastname@example.org.
- CJFS CARES, Tuesdays, 7:00 pm, contact Pam Leonard, email@example.com.
- United Way Area Agency on Aging of Jefferson County, 3rd Tuesday of each month 11:30-12:30, contact Valarie Lawson, firstname.lastname@example.org
- M4A, 2nd Thursday’s, noon – 1 pm. Contact Crystal Whitehead, email@example.com
- M4A, 3rd Wednesday’s 2:00 – 3:00 pm. Contact Crystal Whitehead, firstname.lastname@example.org
- Asbury United Methodist Church1st and 3rd Thursdays at 1:00, contact Maggie Dunaway at email@example.com.
May Webinars from Alabama Lifespan Respite: https://alabamarespite.org/events2/
Sensitivity to specific common odors correlates with symptoms of depression or anxiety, new research shows. A study of more than 400 participants showed that symptoms of anxiety were associated with heightened awareness of floral scents or kitchen smells, while depression was linked to increased awareness of social odors including “good” and “bad” smells of other people. Can Sensitivity to Common Smells Sniff Out Depression, Anxiety? (medscape.com)
The Centers for Medicare and Medicaid Services (CMS) recently announced its decision to deny Medicare coverage of the FDA-approved Alzheimer’s treatments except for patients who participate in highly restrictive clinical trials. The CMS ruling extends to an entire class of drugs known as anti-amyloids that are intended to treat Alzheimer’s disease in its early stages. A recent A-LIST survey asked, “Given what you know, should Medicare cover the cost of FDA-approved drugs to treat Alzheimer’s?” 74% of respondents said Medicare should cover the cost of new Alzheimer’s disease treatments. The mission of the A-LIST is to use survey results to make life better for the broader Alzheimer’s and dementia community. Read the complete survey results Microsoft Word – UsA2 A-LIST WMM CMS survey Information sheet_4.14.22.docx (usagainstalzheimers.org)
Eisai has completed a rolling submission to the U.S. Food and Drug Administration (FDA) to seek approval for lecanemab (BAN2401), an investigational antibody for the treatment of early Alzheimer’s disease accompanied by beta-amyloid deposits in the brain. Accelerated FDA Approval Sought for Lecanemab, Alzheimer’s Treatment (alzheimersnewstoday.com)
If Parkinson’s is in your family, you can play an integral role in our landmark study on a mission to end the disease. The Parkinson’s Progression Markers Initiative (PPMI) urgently needs parents, brothers and sisters, and children (over age 60) of people with Parkinson’s. The online part of the study is open to anyone over age 18 in the U.S. PPMI (myachievement.com)
The neuropsychiatric ramifications of severe COVID-19 infection appear to be no different than for other severe acute respiratory infections (SARI). Results of a large study showed risks of new neuropsychiatric illness were significantly and similarly increased in adults surviving either severe COVID-19 infection or other SARI, compared with the general population. This suggests that disease severity, rather than pathogen, is the most relevant factor in new-onset neuropsychiatric illness. Neuropsychiatric Risks of COVID: New Data (medscape.com)